Previous 10 | Next 10 |
- Findings will be shared in oral presentations at the 2024 Congress of the European Society of Gynaecological Oncology (ESGO) and the 2024 Society for Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer - Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that th...
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that members of the Company’s senior management team will participate in the following investor conference in March 2024: Leerink Partners Global Biopharma Conference 2024 Presentation: Monday, March 11, 2024, 4:00 p.m. E...
Total product revenue of $266.7 million for Full-Year 2023, representing 25% y-o-y growth; 31% y-o-y growth at constant exchange rate (CER) VYVGART ® (efgartigimod alfa injection) was launched in September 2023 in China and we estimate that nearly 1,000 patients were treated ...
2024-02-13 17:50:10 ET More on Zai Lab Zai Lab: Strong Growth Amidst Strategic Shifts (Rating Upgrade) NovoCure Tumor Treating Fields accepted for FDA review Zai Lab, argenx gain as China adds Vyvgart for reimbursement Seeking Alpha’s Quant Rating on Z...
A look at the top 10 most actives in the United States Palantir Technologies Inc. Class A (PLTR) rose 7.9% to $23.6 on volume of 254,911,069 shares MicroCloud Hologram Inc. (HOLO) rose 1092.1% to $18 on volume of 194,069,467 shares Snap Inc. Class A (SNAP) fell 34.6% to $11.41 on volume o...
A look at the top 10 most actives in the United States Palantir Technologies Inc. Class A (PLTR) rose 8.5% to $23.725 on volume of 224,436,172 shares MicroCloud Hologram Inc. (HOLO) rose 602.0% to $10.6 on volume of 173,635,213 shares Snap Inc. Class A (SNAP) fell 34.8% to $11.37 on volum...
2024-02-07 11:28:54 ET More on I-Mab Biopharma Seeking Alpha’s Quant Rating on I-Mab Biopharma Historical earnings data for I-Mab Biopharma Financial information for I-Mab Biopharma Read the full article on Seeking Alpha For further details see...
- Company to Host Conference Call and Webcast on February 28, 2024, at 8:00 a.m. ET (9:00 p.m. HKT) Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that it will report financial results for the year ended December 31, 2023 and recent corporate updates, after the closing of ...
2024-01-23 12:22:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-01-22 10:00:11 ET More on Health Care Select Sector SPDR Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Investors were most bullish on H...
News, Short Squeeze, Breakout and More Instantly...
First and only NMPA-approved subcutaneous (SC) injectable providing additional flexibility and optionality for gMG patients in China Consistent clinical benefit and safety profile of efgartigimod SC compared to IV demonstrated in Phase 3 ADAPT-SC study Zai Lab Limited (NASDAQ: Z...
Manuscript represents the first publication from China’s gynecology oncology field to be published in Cell Publication highlights first-time learnings about the landscape of ovarian cancer microenvironment stratified by HRD and how a PARP inhibitor perturbs it Data suggest ...
2024-07-05 18:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...